Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Canadian Securities Exchange sees 'particularly busy' February featuring 5 IPOs

Published 2023-03-20, 11:25 a/m
Updated 2023-03-20, 11:45 a/m
© Reuters Canadian Securities Exchange sees 'particularly busy' February featuring 5 IPOs

Proactive Investors - The Canadian Securities Exchange unveiled performance statistics for February 2023, which included 10 total new listings and 5 initial public offerings.

The total trading volume of CSE-listed securities was 1.4 billion shares and total trading value was $336 million.

During the month, CSE issuers also completed 78 financings that raised an aggregate $80 million.

"February was a particularly busy month for initial public offerings on the CSE, as five of our 10 new listings during the month arrived via IPO," CSE CEO Richard Carleton said in a statement.

PDAC and podcasts

"On the financing and listing front, mining has been the leader on the exchange so far this year. We were pleased to see so many of our mining issuers at this year's PDAC conference, where attendance was high and investor interest was evident."

The CSE team was active at this year's Prospectors and Developers Association of Canada (PDAC) conference In Toronto, exhibiting at the event and hosting an investor lunch headlined by the president of First Phosphate Corp (CSE:PHOS).

CSE issuers were very well represented at the conference, with more than 30 of them hosting booths at the show.

Elsewhere, the third season of the CSE's Exchange for Entrepreneurs podcast is ongoing. A recent episode marked International Women's Day with a deep dive into the opportunities and challenges women face in a career in the Canadian capital markets featuring CSE chief financial officer Mary Anne Palangio and chief legal officer Tracey Stern.

Another recent episode featured an interview with Todd Shapiro, CEO of Red Light Holland Corp, who discussed his company's expansion from psychotropic mushrooms into the world of exotic mushrooms.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read more on Proactive Investors CA

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.